Herpes simplex virus thymidine kinase (TK) gene transfer followed by ganciclovir (GCV) administration is an approach investigated for glioblastoma treatment. The bystander effect (BE) enhances the cytotoxic effect of this strategy by allowing the diffusion of phosphorylated GCV from TK-expressing cells toward neighboring TK negative cells. This transfer of toxic metabolites is mainly mediated via gap junctions that are composed of connexins. Downregulation and/or cytoplasmic localization of connexins are common in tumors, and should be detrimental to the success of the TK/GCV strategy. In this study, we investigated the level of expression, the localization and the functionality of connexin43 (Cx43) in three glioblastoma cell lines. We showed that Cx43 was predominantly located in lysosomes and late endosomes, with only few gap junctions present at the cell surface. Surprisingly, the gap-junctional intercellular communication (GJIC) and the BE capacity were preserved, and in two of the cell lines analyzed, it was at least twice as high as compared to a control HeLa transfectant that expresses high levels of Cx43 at the cell membrane. Experiments performed in the presence of a-glycyrrhetinic acid or small interfering RNA confirmed that Cx43 was responsible for the GJIC and the BE. Our results indicate for the first time that the very limited numbers of gap junctions present in glioblastoma cells are highly functional. We thus conclude that the TK/GCV strategy is still a valuable therapeutic option to be developed for the treatment of glioblastoma patients.
Glioblastoma patients have a poor prognosis despite aggressive therapies. Surgery combined with radiotherapy and temozolomide, the best chemotherapeutic agent available, leads to a median survival time of 14.6 months after diagnosis. 1 A number of experimental treatments have been developed to improve the survival of glioblastoma patients. The delivery of the herpes simplex virus thymidine kinase (TK) gene followed by ganciclovir (GCV) treatment is one of the strategies that is being investigated. [2] [3] [4] TK phosphorylates GCV that is subsequently converted into the diphosphate and triphosphate forms by cellular kinases. The triphosphate molecule inhibits cellular DNA polymerase by competing with natural nucleotides, and it can also be incorporated by cellular polymerases into elongating DNA, leading to cell death. 5 The cytotoxic potential is enhanced by the bystander effect (BE) that consists of the transfer of phosphorylated GCV from TK-expressing cells toward neighboring TK negative cells. This phenomenon is responsible for the strong antitumoral effect reported in animal models, with complete tumor regressions that could be achieved with only 10% of cells expressing TK. 3, 6, 7 It is noteworthy that transfer of phosphorylated GCV requires cell contact and is mainly mediated via gap junctions. 2, [8] [9] [10] [11] In vertebrates, gap junctions are composed of a family of proteins called connexins that allow passive diffusion of small molecules (p1 kDa) between cells. These molecules can be ions, short peptides or other metabolites including most second messengers such as cAMP, calcium and inositol 1,4,5-triphosphate. 12 Gap junctions play a role in many physiological processes such as contraction of the heart and uterus and electric conduction of impulses in nerves. Gap junctions are made up of six connexin proteins that oligomerize to form a hemichannel at the cellular membrane and dock with a partner protein complex on the adjacent cell. 12 Connexins are differentially expressed in tissues, with the most ubiquitously expressed member being Cx43 (connexins are abbreviated Cx followed by the molecular weight). Mutated forms of connexins are associated with several diseases; for example, mutations in Cx26, Cx30 and Cx31 are involved in non-syndromic deafness and mutations in Cx32 have been linked to Charcot-Marie tooth syndrome. 12 Downregulation or complete loss of connexin expression has been observed in tumors of different tissue origins, including the central nervous system. [13] [14] [15] [16] Also, a cytoplasmic localization of connexins has been found in tumor cell lines and biopsies, as opposed to a natural plasma membrane distribution. 16 In adult brain, Cx43 is abundantly expressed in astrocytes, 17 but the status of Cx43 in gliomas, which are most likely astrocytederived tumors, is not well defined. Although, in most cases Cx43 was found in glioblastoma, the level of expression varied considerably, [18] [19] [20] [21] [22] except in one study where it was undetected. 23 Thus, we hypothesized that altered connexin expression patterns would be an impediment to the BE and therefore would limit the success of the TK/GCV strategy for the treatment of glioblastoma.
In this study, the expression, the precise localization of Cx43, the level of gap-junctional intercellular communication (GJIC) and the BE were assessed in three glioblastoma cell lines. All cell lines studied displayed a cytoplasmic accumulation of Cx43 with few or rare plaques present at the cell surface. Nevertheless, the level of GJIC and the BE measured in SKI-1 and U87 cells was at least twice as high as the one found in HeLa/Cx43 cells that express a high amount of gap junction plaques. In this paper, we showed that in glioblastoma cells, efficient BE does not rely on a high level of Cx43 expression on the cell membrane.
Materials and methods

Cell culture
The HeLa human cervix cancer cell line (ATCC CCL-2), the SKI-1 human glioma cell line and the 293T human embryonic kidney cell line were grown in Dulbecco's modified Eagle's medium (Sigma, St Louis, MO) supplemented with 10% fetal calf serum (Bio Cell, Drummondville, Canada). The U251 and U87 human glioma cell lines were cultured in the same medium complemented with 15% fetal calf serum.
Plasmids
The MFG-green fluorescent protein (GFP)/TK plasmid was constructed as follows: the 1133-bp TK gene, digested in NcoI/BamHI, was cloned in pEGFP-C2 (Clontech, Palo Alto, CA) opened in Ecl136II/BamHI. The GFP/TK fusion gene digested by BamHI/NcoI was then inserted in the retroviral plasmid MFG. 24 The retroviral vector containing the Cx43 gene was derived from a version of the MFG plasmid that contains a polylinker and a neomycin resistance gene linked to an internal ribosomal entry site from encephalomyocarditis virus. The rat Cx43 gene was cloned upstream the neomycin cassette in NotI/EcoRI.
The plasmids pEGFP-Rab7 and pEGFP-Rab11 have been described elsewhere. 25 
DNA transfection and retroviral infection
For the generation of recombinant retroviruses, subconfluent 293T cells were transiently transfected by the calcium phosphate procedure with 9.5 mg of pVpack-GagPol plasmid (Stratagene, La Jolla, CA), 3 mg of pMD2.G encoding the VSV-G envelope and 12.5 mg of the MFG derived retroviral plasmids in a 10-cm tissue culture dish. After 48 h, viral supernatants were harvested, clarified by centrifugation and kept frozen at À80 1C.
Cancer cell lines containing the GFP/TK gene or the Cx43 gene were generated by retroviral transduction at low multiplicity of infection in the presence of polybrene at 8 mg ml À1 (Sigma). The next day, cells infected with the Cx43 vector were selected in G418 (70% active; Invitrogen, Carlsbad, CA) at 700 mg ml À1 for a 10-day period. Cells infected with the GFP/TK vector were enriched for GFP expression with a cell sorter (EPICS Elite ESP, Beckman Coulter, Miami, FL) until more than 95% of the cell population was GFP positive.
For Rab7 and Rab11 immunolocalization, cells were transfected in 35-mm dishes with pEGFP-Rab7 or pEGFP-Rab11 plasmids using polyethyleneimine. Linear 25 kDa polyethyleneimine (Polysciences, Warrington, PA) was dissolved in water at 1 mg ml À1 and sterilized by filtration. A total of 5 mg of polyethyleneimine was added to 2.5 mg DNA in 250 ml Dulbecco's modified Eagle's medium and allowed to stand at room temperature for 15 min before the transfection material was added to cells. Two days later, cells were fixed, immunolabeled for Cx43 and analyzed by confocal microscopy.
Western blot analysis
For each cell line, 10 5 lysed cells were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Proteins were transferred to nitrocellulose membranes that were subsequently incubated with a rabbit polyclonal antibody directed against Cx43 (1:500) (Sigma). The reactive bands were detected using the Western Lightning Chemiluminescence Reagent Plus Kit (Perkin Elmer, Woodbridge, Canada) according to the manufacturer's protocol. Membranes were stripped and rehybridized with a mouse monoclonal anti-b-tubulin antibody (Sigma) for loading comparison.
Immunofluorescence microscopy Cells cultured on glass coverslips in 35-mm dishes were grown until they reached sub-confluency. Cells were fixed in 4% paraformaldehyde, permeabilized with 0.2% Triton X-100 and incubated with a primary antibody raised against Cx43 (1:800) followed by an Alexa594-conjugated goat anti-mouse (1:1000) (Invitrogen). For double labeling experiments, cells were incubated simultaneously with a rabbit anti-Cx43 and with an anti-golgin 97 (1:100; Invitrogen), or with an anti-calnexin (1:250; Chemicon, Temecula, CA), or with an anti-LAMP-1 (1:100; Santa Cruz Biotechnology, Santa Cruz, CA), or cells were loaded for 30 min with 50 mg ml À1 transferrinAlexa488 (Invitrogen). Secondary antibodies were used: anti-mouse IgG coupled to Alexa594 and anti-rabbit IgG coupled to Alexa488.
Cells were observed with a Bio-Rad MRC-1024 confocal microscope mounted on a Nikon Diaphot-TMD equipped with a Â 60 objective lens.
GJIC measured by double-dye flow cytometry
The gap-junctional coupling was measured by flow cytometry. 26 . Next, cells were washed twice with phosphate buffer saline, and calcein-loaded cells were trypsinized and plated on top of the DiI-stained cells at a ratio of 1:10 (donors:recipients). After 6 h of incubation at 37 1C, the cell mixtures were trypsinized and analyzed by flow cytometry. Fluorescence was measured with a Coulter EPICS XL-MCL flow cytometer and Expo32 software (Beckman Coulter, Brea, CA). Similar dye transfer experiments were performed with the gap junction inhibitor a-glycyrrhetinic acid (AGA; Sigma). Cells were incubated with AGA at 70 mM for 24 h before the beginning of the experiment and during its entire course.
siRNA transfection Cells cultured in 6-well plates were transfected with 50 nM of siRNA complex (Santa Cruz Biotechnology) mixed with TransIT-TKO transfection reagent (Mirus, Madison, WI). One day after transfection, cells were either plated for the dye transfer assay, or cell lysates were collected and prepared for western blot analysis.
Bystander assay
The protocol for the bystander experiments has been described previously. 24 Briefly, 2% tumor cells expressing TK were mixed with their respective parental cell lines, at concentrations identical to the ones used for the dye transfer assay. The following day, confluent cells were treated with 10 mM GCV. On day 3, cells were trypsinized and a 1:100 dilution of the cells was distributed into 96-well plates in five replicates. Cells were cultured subsequently in the presence of GCV for 3 days and cell proliferation was measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 27 A final concentration of 0.5 mg ml À1 of MTT was added to the wells and the plates were incubated at 37 1C for 2 h. After medium removal, 150 ml of dimethyl sulfoxide was added and the plates were gently shaken for 10 min to dissolve the formazan blue crystals. The absorbance was then measured at 595 nm with a microplate reader (Tecan, Research Triangle Park, NC). The percentage of bystander cells killed was calculated according to the GCV cytotoxicity effect on 100% parental and 100% TKpositive cells using the formula: percentage of bystander cells killed ¼ [(98% parental cells survival rate þ 2% TK cells survival rate)-survival rate for parental/TK cells mix]. Bystander effect experiments were also performed in the presence of AGA.
Results
Cx43 expression and localization in glioma cell lines
The level of expression of Cx43 was investigated in the glioblastoma cell lines U251, SKI-1 and U87. HeLa cells infected or not infected with a retroviral vector expressing Cx43 (HeLa/Cx43) were used as positive and negative controls, respectively. Various immunoreactive isoforms of Cx43 corresponding to non-phosphorylated (lower band) and phosphorylated Cx43 (upper bands) were detected by western blot with HeLa/Cx43 cells. As reported by others, the treatment of cellular extracts with alkaline phosphatase gave rise only to the lower band (data not shown; 28 ). A similar Cx43 detection pattern was seen with SKI-1 and U87 cells, but the amount of Cx43 was slightly lower. With U251 cells, the phosphorylated Cx43 isoforms were much less abundant (Figure 1a) .
The cellular localization of Cx43 in SKI-1, U87 and U251 cell lines was next assessed by immunofluorescence. In HeLa/Cx43 cells, Cx43 was immunolocalized at the lateral plasma membrane as distinct large spots and streaks at regions of cell-cell contact, representative of gap-junctional plaques. On the contrary, very little Cx43 was present at the surface of U87 and SKI-1 cells, and very rarely could it be detected at the surface of U251 cells. In these glioblastoma cell lines, Cx43 was predominantly located in cytoplasmic perinuclear compartments (Figure 1b) .
Co-immunolabeling studies for Cx43 were then performed to pinpoint the exact cellular location of Cx43 in Bystander effect in glioblastoma cells S Cottin et al SKI-1 and U251 cells. The staining with antibodies directed against calnexin and golgin 97, specific endoplasmic reticulum and Golgi apparatus proteins, revealed that Cx43 did not accumulate in these compartments in SKI-1 and U251 cell lines (data not shown). On the contrary, Cx43 was found in lysosomes in both cell lines as Cx43 co-localized with the lysosome-associated membrane protein-1 (LAMP-1; Figures 2a-f) . As the co-localization was not complete in lysosomes, the presence of Cx43 was also assessed in the endosomal compartment using a fluorescently labeled-transferrin. In SKI-1 and U251 cells, Cx43 was able to co-localize with the endocytosed transferrin (Figures 2g-l) .
Transferrin can be present in early and/or recycling endosomes; therefore, a specific marker of the latter one was used to specifically assess the presence of Cx43 in the endosomal compartment. Plasmids containing GFP fused to Rab11, a small GTPase that is a marker of the endocytic/recycling pathway, were transfected in glioblastoma cells. Cx43 did not co-localize with Rab11 Figure 2 Co-localization of Cx43 with intracellular compartment markers. Immunofluorecence of Cx43 was performed on SKI-1 and U251 cells with lysosome-associated membrane protein-1 (LAMP1) (a-f) and with Tf-Alexa488 (g-l). For the purpose of the figure Tf-Alexa488 and antiCx43 were artificially colored in red and green, respectively. Resulting co-localization in merged images is yellow.
Bystander effect in glioblastoma cells
S Cottin et al (Figures 3a-f ), suggesting that Cx43 was present with transferrin in early endosomes. Late endosomes were next assessed for the presence of Cx43 using a similar approach. Rab7 is a small GTPase present in late endosomes, and a plasmid expressing Rab7 fused to GFP was transfected in glioblastoma cells to evaluate the presence of Cx43 in this endosomal compartment. With both glioblastoma cell lines, a co-localization of Cx43 was observed with Rab7 (Figures 3g-l) . Overall, these results indicated that Cx43 does not accumulate in the Golgi apparatus or the endoplasmic reticulum, but that it is found primarily in lysosomes and in late endosomes.
Cell coupling in glioma cell lines
The predominant cytoplasmic localization of Cx43 and the small amount of gap junction plaques in glioblastoma cell lines should theoretically impair the cellular functional coupling. A dye-loading technique combined with fluorescence-activated flow cytometry was then used to quantify GJIC in glioblastoma cell lines. 26 Cells were loaded with the membrane-permeable dye calcein AM Figure 3 Co-localization of Cx43 with specific endosome markers. Immunofluorecence of Cx43 was performed on SKI-1 and U251 cells transiently transfected with plasmids expressing Rab11-GFP (a-f) or Rab7-GFP (g-l). Resulting co-localization in merged images is yellow. (Figure 4a) . The dye-transfer assay was then performed in the presence of AGA, a specific GJIC inhibitor. 29 Similar to HeLa/Cx43, AGA completely inhibited dye transfer in SKI-1 cells. With U251 and U87 cells, GJIC was inhibited by 42 and 60%, respectively (Figure 4b) . A role of Cx32 and Cx26 on GJIC can be excluded, as these two connexin members normally expressed in the brain were not detected by immunofluorescence (data not shown). However, another connexin member could be responsible for GJIC in these cell lines that would be sensitive to AGA inhibition. So, chemically synthesized small interfering RNA (siRNA) against Cx43 were transfected into cells to ensure that Cx43 was involved in GJIC. As shown by western blot, Cx43 expression was inhibited by the siRNA/Cx43 in all cell lines tested as compared to the same cells transfected with a control siRNA (Figure 4c ). This downregulation of Cx43 resulted in an inhibition of GJIC of 19.8, 42.7 and 44% for SKI-1, U251 and U87 cells, respectively (Figure 4d) . These results showed that SKI-1, U251 and U87 cells are capable of GJIC that is predominantly mediated by Cx43.
Bystander effect in glioblastoma cells
Next, we assessed the BE in glioblastoma cells. GCV sensitivity experiments were performed with 2% glioblastoma cells expressing TK and 98% parental cells. 
S Cottin et al TK-positive cells were generated by infection with a retroviral vector expressing a GFP/TK fusion protein, followed by cell sorting for GFP fluorescence. As measured by the MTT assay, a strong BE was obtained in presence of 10 mM GCV with SKI-1 and U87 cells. Indeed, 64.9% parental SKI-1 cells and 48.6% U87 parental cells were killed with GCV when mixed with only 2% TKexpressing cells. Although the BE was less potent in U251 cells, but it was still sufficient to mediate the killing of 27.6% parental cells by 2% TK-positive cells; this level was in the same range than the one found with HeLa/ Cx43 cells. With the three glioblastoma cell lines and HeLa/Cx43, the BE was strongly inhibited in the presence of AGA and an average of 10% parental cells were killed by GCV in the presence of AGA ( Figure 5 ). These results indicated that these glioblastoma cell lines can display a connexin-dependent BE.
Discussion
Lack of expression or cytoplasmic localization of connexins is frequent in tumor cells and lead to a loss of GJIC. 30 In this study, the presence, the localization and the functionality of gap junctions were investigated in glioblastoma cell lines. We found a predominant intracellular accumulation of Cx43 in these cells, with few or rare plaques detectable at the cell surface (Figure 1b) . Despite the Cx43 aberrant accumulation, the cell lines were able to form GJIC and to mediate a BE. Treatment with AGA and siRNA directed against Cx43 showed that GJIC in these glioblastoma cells was mainly dependent on Cx43 (Figures 4b-d) . The levels of GJIC measured with the dye transfer assay in U87 and SKI-1 cell lines were surprisingly high considering the small amount of Cx43 present at the cell surface. In comparison, HeLa/Cx43 cells had a high level of Cx43 assembled into punctate gap junction plaques at the cellular membrane, but the dye transfer values measured with HeLa/Cx43 cells were only half of the ones found with U87 and SKI-1 cells (Figure 4a) . Similarly, the BE was two to three times more potent with U87 and SKI-1 cells than with HeLa/ Cx43 cells ( Figure 5 ). In a previous study, Cx43 was found in a perinuclear area of colon cancer cell lines, and as expected, the BE could not be detected with these cells. 31 In sharp contrast, the few gap junctions present on U87 and SKI-1 cells are highly functional as compared to those located at the cellular membrane of HeLa/Cx43 cells. The phosphorylation status of Cx43 was shown to play a role in the modulation of GJIC, and a different phosphorylation pattern between these glioblastoma cells and HeLa/Cx43 cells could be responsible for the difference in the level of GJIC. 28 An earlier report suggested that the BE was variable in glioblastoma cell lines, but the presence and the localization of Cx43 were not investigated in this study. 32 The presence of Cx43 has also been investigated in primary glioma tumors with mixed results. It was observed that Cx43 could be downregulated in highgrade gliomas, 18, 20, 22, 23 and in few studies, Cx43 was able to form plaques at the plasma membrane of glioblastoma primary cell cultures. 18, 21 On the contrary, the immunocytochemical analysis of epilepsy-associated tumors suggested an intracytoplasmic localization of Cx43. 20 Future studies including a large number of glioblastoma biopsies and primary cultures will be needed to unveil this discrepancy and to statistically assess the presence and the localization of Cx43. The use of primary glioblastoma cultures would also allow the measure of GJIC.
The TK/GCV strategy has been widely tested in preclinical studies as well as in patients and encouraging results from a randomized glioblastoma clinical trial have been published. In this trial, patients from the control group that received the standard care consisting of radical excision followed by radiotherapy had a mean survival of 39 weeks. A dramatic increase in survival to 70.6 weeks was achieved with the group that received the same treatment followed by gene therapy. 33 Given our results that suggest that a predominant aberrant localization of Cx43 is compatible with highly functional gap junctions, we assume that the clinical success reported in this trial relies on a preserved BE.
In our study, the aberrant localization of Cx43 in glioblastoma cells was primarily identified to lysosomes and late endosomes (Figures 2 and 3) . A similar Cx43 accumulation in lysosomes was also reported in one breast tumor cell line but the localization of Cx43 in the endosomal compartment was not investigated. 34 In another study, Cx43 was sequestered within early endosomes in a mouse model of testis tumors and was associated in situ to uncontrolled Leydig cell proliferation. 35 Accumulation in the Golgi apparatus has also been described in the rat mammary BICR-M1R k tumor cell line and in human testicular seminoma cells. 36, 37 The specific Cx43 intracellular localization is then variable and dependent on the tumor type. It is believed that the cytoplasmic localization of connexin in cancer cells is associated with an impaired trafficking ability to the cellular membrane, 16 but our results clearly indicate that functional Cx43 still reaches the cell surface of U87 and SKI-1 cells.
In conclusion, we have specifically identified a predominant intracellular localization of Cx43 in late endosomes and lysosomes in human glioblastoma cells. Contrary to other tumor types, the GJIC and the BE are still preserved with these cells, rendering the TK/GCV strategy a valuable therapeutic option to be developed for the treatment of glioblastoma patients.
